Melanotan I: LiverTox Database Entry
Low Confidence ReviewOutcomes summary
Comprehensive database entry documenting published clinical reports of liver injury associated with Melanotan I (afamelanotide and related compounds); summarizes hepatotoxicity cases, clinical features, laboratory findings, and potential mechanisms of liver injury from melanocortin-based peptides undergoing clinical development or post-market surveillance.
Limitations
Database entry based on case reports and literature review; relies on published reports which may be subject to publication bias; causality assessment in hepatotoxicity cases can be challenging; comprehensive safety profile requires ongoing post-marketing surveillance and additional clinical data.
Notes
Primary source: LiverTox Database (National Institute of Diabetes and Digestive and Kidney Diseases, 2024).